首页> Journal of thrombosis and haemostasis : JTH> Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.

Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.

导出原文传递

翻译打印收藏纠错

第一作者： C,Delierneux

第一单位： Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium.

作者： C,Delierneux ^[1] ; N,Donis ^[1] ; L,Servais ^[1] ; O,Wéra ^[1] ; C,Lecut ^[2] ; M,Vandereyken ^[3] ; L,Musumeci ^[1] ; S,Rahmouni ^[3] ; J,Schneider ^[4] ; J A,Eble ^[5] ; P,Lancellotti ^[6] ; C,Oury ^[1]

作者单位： Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium. ^[1] Department of Laboratory Hematology, CHU Sart-Tilman, Liège, Belgium. ^[2] Immunology and Infectious Diseases Unit, GIGA-Signal Transduction, University of Liège, Liège, Belgium. ^[3] Luxembourg Center for Systems Biomedicine, University of Luxembourg, Luxembourg City, Luxembourg. ^[4] Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany. ^[5] Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium.;Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy. ^[6]

关键词 CLEC-2 protein CPG-ODN P2Y12 purinoceptor immunotherapy platelet activation